Envoy Medical, Inc.
COCHHealthcareNASDAQMedical Devices · Last scanned Jul 22, 2026
Scan Results
Daily timeframeEnvoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The $52.4M market capitalization puts COCH squarely in micro-cap range for its industry. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire.
Market Cap
$52.4M
Beta
1.86
P/E (TTM)
—
P/E (Fwd)
-3.58
EPS (TTM)
$-1.04
EPS (Fwd)
$-0.19
ROE
—
ROA
-71.3%
Cash
$25.3M
Total Debt
$889,000
Free CF
-$7.9M
52W Change
-57.7%
Annual Financials
Cash vs Debt
Where COCH stands vs its 150-day and 200-day moving averages
As of the July 15, 2026 close, COCH finished 10.14% above its 150-day moving average ($0.69) and 5.56% above its 200-day moving average ($0.72). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is COCH overbought or oversold?
At the July 15, 2026 close, COCH's RSI(14) was 61.6, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Envoy Medical, Inc. holds $25.3M in cash against $889K in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow is running at -$7.9M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Revenue has been relatively flat, moving from $237K (2022) to $241K (2025).
Envoy Medical, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. With cash comfortably exceeding debt, COCH has financial flexibility that may help navigate uncertain periods. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Envoy Medical, Inc. and its sector.